Literature DB >> 12112163

Very early-onset familial Alzheimer's disease: a novel presenilin 1 mutation.

Jill S Goldman1, Bruce Reed, Rosalie Gearhart, Joel H Kramer, Bruce L Miller.   

Abstract

BACKGROUND: Early-onset familial Alzheimer's disease (EOFAD) is linked to mutations in three autosomal dominant genes: PS1, PS2 and APP. The clinical presentation and age of onset of mutations is variable.
OBJECTIVES: The aim of this report is to describe a novel PS1 mutation believed to be causal for a very early onset of AD.
METHODS: This is a case history using information from medical records, relative interviews and genetic testing results to describe the pre-clinical prodrome and clinical course of a patient with EOFAD.
RESULTS: A previously undescribed G206V mutation in PS1 was found in the proband.
CONCLUSION: The G206V mutation in PS1 is probably causal of a case of EOFAD with significant premorbid features. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112163     DOI: 10.1002/gps.657

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  10 in total

1.  G206D Mutation of Presenilin-1 Reduces Pen2 Interaction, Increases Aβ42/Aβ40 Ratio and Elevates ER Ca(2+) Accumulation.

Authors:  Wei-Ting Chen; Yi-Fang Hsieh; Yan-Jing Huang; Che-Ching Lin; Yen-Tung Lin; Yu-Chao Liu; Cheng-Chang Lien; Irene Han-Juo Cheng
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

Review 2.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

3.  Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation.

Authors:  Steven P Cercy; Martin J Sadowski; Thomas Wisniewski
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

4.  Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.

Authors:  Anna A Pimenova; Alison M Goate
Journal:  Neurobiol Dis       Date:  2020-02-04       Impact factor: 5.996

Review 5.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

Review 6.  Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease.

Authors:  D Farfara; V Lifshitz; D Frenkel
Journal:  J Cell Mol Med       Date:  2008-03-20       Impact factor: 5.310

7.  Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.

Authors:  Yuno Song; Hong-Duck Kim; Min-Kwon Lee; Il-Hwa Hong; Chung-Kil Won; Hyoung-Woo Bai; Seung Sik Lee; SungBeom Lee; Byung Yeoup Chung; Jae-Hyeon Cho
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

8.  Two Novel Mutations and a de novo Mutation in PSEN1 in Early-onset Alzheimer's Disease.

Authors:  Yu-Sheng Li; Zhi-Hua Yang; Yao Zhang; Jing Yang; Dan-Dan Shang; Shu-Yu Zhang; Jun Wu; Yan Ji; Lu Zhao; Chang-He Shi; Yu-Ming Xu
Journal:  Aging Dis       Date:  2019-08-01       Impact factor: 6.745

Review 9.  The genetics of Alzheimer's disease.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2014-04-01       Impact factor: 4.458

Review 10.  Gene mutations associated with early onset familial Alzheimer's disease in China: An overview and current status.

Authors:  Qi Qin; Yunsi Yin; Yan Wang; Yuanyuan Lu; Yi Tang; Jianping Jia
Journal:  Mol Genet Genomic Med       Date:  2020-08-06       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.